Correction: The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease

Chih-Jen Wu; Cheng-Yi Chen; Thung-S. Lai; Pei-Chen Wu; Chih-Kuang Chuang; Fang-Ju Sun; Hsuan-Liang Liu; Han-Hsiang Chen; Hung-I. Yeh; Chih-Sheng Lin; Cheng-Jui Lin

doi:10.18632/oncotarget.26782

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease

PDF | How to cite

Oncotarget. 2019; 10:2006-2006. https://doi.org/10.18632/oncotarget.26782

Metrics: PDF 1492 views | ?

Chih-Jen Wu^1,2,3, Cheng-Yi Chen^1,8,11, Thung-S. Lai⁴, Pei-Chen Wu¹, Chih-Kuang Chuang^5,6,7, Fang-Ju Sun^8,9, Hsuan-Liang Liu⁵, Han-Hsiang Chen^1,8, Hung-I. Yeh¹⁰, Chih-Sheng Lin¹¹ and Cheng-Jui Lin^1,5,8

¹ Division of Nephrology, Department of Internal Medicine, Mackay Memorial Hospital, Mackay Medical College ,Taipei, Taiwan
² Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan
³ Graduate Institute of Medical Sciences and Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
⁴ Graduate Institute of Biomedical Science, Mackay Medical College, New Taipei City, Taiwan
⁵ Institute of Biotechnology, National Taipei University of Technology, Taipei, Taiwan
⁶ Division of Genetics and Metabolism, Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
⁷ College of Medicine, Fu-Jen Catholic University, Taipei, Taiwan
⁸ Mackay Junior College of Medicine, Nursing and Management, Taipei, Taiwan
⁹ Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
¹⁰ Department of Medicine, Mackay Medical College, New Taipei City, Taiwan
¹¹ Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan

Published: March 08, 2019

This article has been corrected: The correct affiliation information is given below:

¹¹ Department of Biological Science and Technology, National Chiao Tung University, Hsinchu, Taiwan

Original article: Oncotarget. 2017; 8:83030-83037. DOI: https://doi.org/10.18632/oncotarget.18789.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26782

Publication Alerts

Corrections:

Correction: The role of indoxyl sulfate in renal anemia in patients with chronic kidney disease